PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $109,085 | -20.1% | 10,560 | +1.4% | 0.00% | – |
Q2 2023 | $136,475 | -39.1% | 10,410 | +48.9% | 0.00% | – |
Q4 2021 | $224,000 | -9.7% | 6,990 | +1.5% | 0.00% | – |
Q3 2021 | $248,000 | -18.4% | 6,887 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $304,000 | – | 6,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |